79279344 - CLINIMACS CELL FACTORY

Information

• Trademark
• 79279344

• Source

• Serial Number

  79279344

• Registration Number

  6242135

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  October 10, 2019
  5 years ago

• Registration Date

  January 12, 2021
  4 years ago

• Transaction Date

  May 11, 2021
  3 years ago

• Status Date

  January 12, 2021
  4 years ago

• Published for Opposition Date

  October 27, 2020
  4 years ago

• Location Date

  January 12, 2021
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  LEASER, ANDREW C

• Law Office Assigned Location Code

  M80

• Owners

  • MILTENYI BIOTEC GMBH

Case File Statements

• D10000: "CELL FACTORY"
• GS0011: Chemicals and/or biological preparations for use in industry and science; diagnostic preparations for scientific or research use including medical laboratory diagnosis; chemicals, biological and biochemical preparations for use in separation processes for biological materials, in particular nucleic acid for laboratory use; reagents for scientific and research use, namely, reagents for cell separation, labelling reagents; chemicals for scientific use and for use in medical laboratories for use in separation processes for biological materials; molecules of microorganisms including viruses, bacteria, fungi, in particular proteins, peptides, and protein and peptide pools, oligosaccharides, lipids, hybridization solutions, chemical preparations for cleaning purposes, cDNA clones, all for use in industry and science; reagents, chemical and/or biological media, materials and components for preparing media, all of the aforesaid for industrial and scientific purposes and for use in medical laboratories; reagents for use in science and/or industry for processing, separating, isolating, enriching, expanding, differentiating, depleting, detecting, screening, analyzing and tallying material, in particular chemicals and biological material, reagents featuring magnetic beads, antibody reagents; buffer solutions and reagents for use with laboratory apparatus, in particular separation apparatus, analyzers, reactors, cell processing apparatus and imaging apparatus; reagents for use in science and/or industry for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; chemical reagents and preparations for use in the manufacture of medicines; culture media, cell culture media, freezing media for in vivo scientific use; reagents other than for medical purposes for use in biotechnology, in biological processing operations and in the biotechnology industry, and the manufacture of medicine; chemicals and biological preparations for use in industry and science; diagnostic preparations for scientific or research use; chemical and/or biological substances and mixtures for industrial and scientific applications in preparing media; culture media for scientific use, namely, biology, microbiology, and for use in the biotechnical industry and in medical research; chemical preparations for use in pharmaceutical and medical science; reagents for clinical and non-clinical laboratory use, in particular cytokines and antibodies
• GS0051: Pharmaceutical and medical preparations for the treatment of cancer, heart disease, diabetes, and blood disorders; biochemical, in particular immunological preparations in the nature of immunostimulants, vaccines, and cells for medical and pharmaceutical purposes; absorbents for therapeutic purposes in the field of extracorporeal plasma treatment, namely, peptide adsorbents; pharmaceutical preparations and pharmaceuticals in the field of extracorporeal plasma therapy, namely, blood purifying preparations, extracorporeal plasma therapy solutions, physiological saline solutions, glycine solutions, PBS solutions, preparations for extending blood coagulation time, heparin solutions; biochemical preparations for medical and pharmaceutical purposes in the field of extracorporeal plasma, in particular immunological preparations for the prevention and treatment of diseases and disorders of the immune system; reagents and cell growth media, and substances and components for the preparation of cell growth media, all being for medical purposes; reagents for processing, separating, isolating, enriching, depleting, detecting, expanding, differentiating, screening, analyzing and tallying biological material, reagents containing magnetic beads, and antibody reagents, all for medical purposes; buffer solutions and reagents for use with medical apparatus, in particular separation apparatus, analyzers, reactors, cell processing apparatus and imaging apparatus; reagents for processing biological material, in particular tissues, bone marrow, cells, blood and components thereof, all being for medical purposes; reagents for medical use and preparations for medical purposes for the treatment of cancer, heart disease, diabetes and blood disorders; culture media for cultivating human cells and human tissue, cell culture media for cultivating human cells and human tissue, freezing media for the cryopreservation of human cells and human tissue, contrast agents and contract agents for in vivo imaging, all of the aforesaid goods for medical, pharmaceutical purposes; cellular medicines and pharmaceutical treatments for the treatment of cancer, heart disease, diabetes and blood disorders; chemical, biochemical and biological preparations for pharmaceutical and medical purposes for the treatment of cancer, heart disease, diabetes, and blood disorders; molecules of microorganisms including viruses, bacteria, fungi, in particular proteins, peptides, and protein and peptide pools, all for medical purposes; freezing preparations for medical purposes for the cryopreservation of human cells and human tissues; diagnostic preparations and substances for medical purposes; media for cell culture for cultivating human cells and human tissue; media for bacteriological cultures for medical purposes; cell cultures, fungal cultures and virus cultures, all for medical purposes; pharmaceuticals for cellular therapy; reagents for medical use, in particular cytokines and antibodies
• GS0091: Scientific apparatus and instruments for magnetic cell separation for use in clinical and non-clinical laboratories; apparatus and instruments for use in clinical and non-clinical laboratories, in particular an automated system for processing cells; test tube sets for scientific purposes; chromatography columns for laboratory use; laboratory centrifuges; laboratory incubators; laboratory bioreactors; component and replacement parts for all the mentioned goods; scientific, electric and electronic apparatus and instruments for separating biological material for scientific use, in particular for separating cells and biological macro-molecules, in particular proteins, nucleic acids; scientific, electric and electronic apparatus and instruments for conducting enzymatic reactions for scientific use; liquid and gas analyzers, and recorded control software, laboratory pipetting stations and laboratory sample carrier plates therefor; scientific apparatus and instruments for magnetically sorting biological material, and computer hardware and recorded computer operating software therefor; cell separation and cell processing apparatus for laboratory use; cytometers; microchips and data carriers containing recorded software for use with gene detecting apparatus, namely, for indicating pathological changes; microchips in the form of coated glass slides or plastic materials; microchips and testing instruments for the diagnostic detection of gene expression profiles indicative of pathological changes for scientific research use; electric and electronic apparatus and instruments for cell separation and for cell processing, for use in clinical and non-clinical laboratories; sacks, pouches, bags and films specially adapted for the holding of cell culture and biotechnological preparations for scientific or laboratory use, in particular for cryopreservation; component and replacement parts for all the mentioned goods
• GS0101: Medical apparatus and instruments, namely, apparatus and instruments for magnetic cell separation for medical purposes; apparatus and instruments for medical use, in particular an automated system for processing cells; blood tube sets for medical purposes; analysis columns for medical purposes, for blood analysis; incubation units for medical purposes; bio-reactors for medical purposes for cell culturing; component and replacement parts for the aforesaid goods; medical apparatus for extracorporeal immunoadsorption; medical apparatus and equipment for extracorporeal plasma therapy and component and replacement parts and fittings therefor, in particular sterile bottles, filters, membrane filters, cannulae and tubes for medical purposes, being replaceable parts; chromatography columns for medical use, in particular adsorption columns and cartridges for use in extra-corporal plasma therapy; medical apparatus and equipment for separating plasma and component and replacement parts and fittings therefor, in particular sterile bottles, filters, membrane filters and tubes for medical purposes, being replaceable parts; extracorporeal plasma therapy systems for medical purposes comprised of units for separating plasma, plastic containers and bags for plasma for medical purposes, plasma filter and collecting tubes, sterile filters for medical purposes, control units, microprocessors, pumps, monitors, pH detectors, air detectors and photodetectors, optical detectors; medical apparatus in the nature of absorber cartridges and columns for use in extracorporeal plasma therapy; medical apparatus and equipment for separating plasma; apparatus for magnetic cell separation for medical purposes; sacks, pouches, bags, foils, hoses and connectors adapted for medical use, in particular for cryopreservation of human cells and human tissues; chromatography columns for medical use, in particular immune adsorption columns for ex-vivo application in therapy; medical measuring apparatus and instruments, namely, flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; component and replacement parts for the aforesaid goods
• GS0421: Scientific and technological services, namely, research and design in the field of computer hardware and software for the analysis of biological and biochemical materials ; industrial analysis and research services; design and development of computer hardware and computer software, all of the aforesaid services for and in connection with the analysis of biological material, in particular cell material for biological and medical research and therapy; scientific services relating to the isolation and cultivation of cell materials for biological and medical research and therapy; design and development of laboratory processes for manufacturing cell products; design and development of computer hardware and software, in connection with manufacturing cell preparations, selecting, stimulating, activating cells for medical, scientific, pharmaceutical or biotechnological purposes, and products necessary therefor; development of software in the field of molecular biology; biotechnological laboratory services, in particular in connection with manufacturing cell therapy products, cell preparations, cellular medicines, selecting, stimulating, activating cells, and manufacturing kits or reagents; chemistry, biology and molecular biology laboratory services; design and development of manufacturing processes for medical cell preparations
• GS0441: Medical and pharmaceutical compounding services; medical, pharmaceutical laboratory services, in particular providing medical and pharmaceutical consultation in connection with manufacturing cell therapy products, cell preparations, cellular medicines, selecting, stimulating, activating cells, and manufacturing kits or reagents; medical services, in particular in the field of extracorporeal plasma therapy; medical analysis services for diagnostic and treatment purposes provided by medical laboratories

Case File Event Statements

• 5/11/2021 - 3 years ago

  47 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 4/19/2021 - 3 years ago

  46 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 4/19/2021 - 3 years ago

  45 - FINAL DISPOSITION PROCESSED Type: FIMP

• 4/12/2021 - 3 years ago

  44 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 1/12/2021 - 4 years ago

  43 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 10/27/2020 - 4 years ago

  42 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/27/2020 - 4 years ago

  41 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/25/2020 - 4 years ago

  40 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 10/7/2020 - 4 years ago

  39 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 10/7/2020 - 4 years ago

  38 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 10/7/2020 - 4 years ago

  37 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 9/23/2020 - 4 years ago

  36 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 9/18/2020 - 4 years ago

  35 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD

• 9/16/2020 - 4 years ago

  34 - ASSIGNED TO LIE Type: ALIE

• 9/3/2020 - 4 years ago

  33 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/3/2020 - 4 years ago

  32 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 9/3/2020 - 4 years ago

  31 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 9/3/2020 - 4 years ago

  30 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 9/3/2020 - 4 years ago

  29 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 9/3/2020 - 4 years ago

  28 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 8/29/2020 - 4 years ago

  27 - WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST Type: ISSR

• 7/31/2020 - 4 years ago

  26 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 7/28/2020 - 4 years ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/28/2020 - 4 years ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/15/2020 - 4 years ago

  23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 7/15/2020 - 4 years ago

  22 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 7/8/2020 - 4 years ago

  21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/22/2020 - 4 years ago

  20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/6/2020 - 4 years ago

  19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 6/6/2020 - 4 years ago

  18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 6/6/2020 - 4 years ago

  17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 6/6/2020 - 4 years ago

  16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 5/27/2020 - 4 years ago

  15 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/27/2020 - 4 years ago

  14 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/27/2020 - 4 years ago

  13 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/7/2020 - 4 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/6/2020 - 4 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/6/2020 - 4 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/10/2020 - 4 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 3/24/2020 - 4 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 3/24/2020 - 4 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 3/4/2020 - 5 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 3/3/2020 - 5 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/29/2020 - 5 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 2/25/2020 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/25/2020 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 2/20/2020 - 5 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR